Smruthi Organic

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE172E01011
  • NSEID:
  • BSEID: 540686
INR
99.00
-7.9 (-7.39%)
BSENSE

Mar 30

BSE+NSE Vol: 9.45 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

9.45 k (82.11%) Volume

Shareholding (Dec 2025)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

64.73%

Who are in the management team of Smruthi Organic?

06-Jun-2025

As of March 2023, the management team of Smruthi Organic includes E Purushotham (Chairman & Managing Director), E Swapnil (Joint Managing Director & CFO), and several independent directors, along with a Company Secretary. They oversee the company's operations and strategic direction.

As of March 2023, the management team of Smruthi Organic includes:<BR><BR>1. E Purushotham - Chairman & Managing Director<BR>2. E Swapnil - Joint Managing Director & CFO<BR>3. J H Ranade - Independent Director<BR>4. K Ramaswamy - Independent Director<BR>5. Kashinath R Dhole - Independent Director<BR>6. Urvashi D Khanna - Company Secretary & Compliance Officer<BR>7. E. Smruthi - Non-Executive & Non-Independent Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

View full answer

What is the bonus history of the Smruthi Organic?

06-Jun-2025

Smruthi Organic announced a 2:1 bonus issue on March 16, 2021, with a record date of March 17, 2021, allowing shareholders to receive two additional shares for every one share held.

Smruthi Organic has a bonus history that includes a 2:1 bonus issue announced on March 16, 2021. The record date for this bonus was March 17, 2021. This means that shareholders received two additional shares for every one share they held as of the record date. If you have any more questions about the company or its financial activities, feel free to ask!

View full answer

Has Smruthi Organic declared dividend?

06-Jun-2025

Yes, Smruthi Organics Ltd has declared a 15% dividend, amounting to ₹1.5 per share, with an ex-date of June 13, 2025. Despite recent volatility, the company has shown a strong recovery over the past five years, yielding a total return of 279.01%.

Smruthi Organics Ltd has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 15%<BR>- Amount per share: 1.5<BR>- Ex-date: 13 Jun 25<BR><BR>Dividend Yield: 1.16%<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -1.08%, the dividend return was 1.17%, resulting in a total return of 0.09%.<BR><BR>Over the past year, the price return was -21.76%, with a dividend return of 1.75%, leading to a total return of -20.01%.<BR><BR>In the 2-year period, the price return was -12.23%, while the dividend return was 3.86%, resulting in a total return of -8.37%.<BR><BR>For the 3-year period, the price return was -27.96%, the dividend return was 5.03%, culminating in a total return of -22.93%.<BR><BR>In the last 4 years, the price return was -50.94%, with a dividend return of 3.54%, resulting in a total return of -47.4%.<BR><BR>Finally, over the 5-year period, the price return was 252.55%, the dividend return was 26.46%, leading to a total return of 279.01%.<BR><BR>Overall, while Smruthi Organics Ltd has declared a dividend, the total returns over various periods show significant volatility, with negative returns in most periods except for the 5-year period, which indicates a strong recovery in the long term.

View full answer

Who are the peers of the Smruthi Organic?

03-Jun-2025

Smruthi Organic's peers include Sun Pharma, Divi's Lab, Cipla, Torrent Pharma, Dr Reddy's Labs, and others. In terms of performance, Smruthi Organic has a 1-year return of -22.54%, with growth and management risk rated below average compared to its peers.

Peers: The peers of Smruthi Organic are Sun Pharma.Inds., Divi's Lab., Cipla, Torrent Pharma, Dr Reddy's Labs, Denis Chem Lab, BDH Industries, Tyche Industries, Quest, and Sotac Pharma.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sun Pharma.Inds., Cipla, Dr Reddy's Labs, BDH Industries, Tyche Industries, and Quest, while Average management risk is found at Denis Chem Lab. Growth is excellent at Sun Pharma.Inds., Cipla, and Dr Reddy's Labs, while below average growth is noted for Divi's Lab., Torrent Pharma, Smruthi Organic, Denis Chem Lab, BDH Industries, and Tyche Industries. Excellent capital structure is seen in Sun Pharma.Inds., Cipla, Dr Reddy's Labs, Smruthi Organic, Denis Chem Lab, BDH Industries, Tyche Industries, and the rest.<BR><BR>Return Snapshot: Divi's Lab. has the highest 1-year return at 51.96%, while Denis Chem Lab has the lowest at -38.43%. Smruthi Organic's 1-year return is -22.54%, which is significantly lower than Divi's Lab. and higher than Denis Chem Lab. Additionally, BDH Industries, Tyche Industries, and Denis Chem Lab have negative six-month returns.

View full answer

Is Smruthi Organic overvalued or undervalued?

09-Jun-2025

As of May 6, 2025, Smruthi Organic is considered undervalued with a PE ratio of 41.20 and an attractive valuation compared to peers, despite a recent 1-year return of -19.68%, while maintaining a strong long-term outlook with a 5-year return of 311.48%.

As of 6 May 2025, the valuation grade for Smruthi Organic has moved from expensive to attractive, indicating a shift in market perception. The company is currently assessed as undervalued. Key ratios include a PE ratio of 41.20, an EV to EBITDA of 13.44, and a PEG ratio of 0.00, which suggests potential for growth relative to its price.<BR><BR>In comparison to its peers, Smruthi Organic's PE ratio is higher than Sun Pharma's 35.25 but lower than Divi's Lab's significantly high 79.33. Additionally, while Cipla has an attractive valuation with an EV to EBITDA of 15.93, Smruthi's lower EV to EBITDA indicates it may be undervalued relative to its earnings potential. Notably, despite recent underperformance with a 1-year return of -19.68% compared to the Sensex's 7.62%, the long-term outlook remains positive with a 5-year return of 311.48%.

View full answer

What is the technical trend for Smruthi Organic?

09-Jun-2025

As of May 12, 2025, Smruthi Organic's trend is mildly bearish, with conflicting signals from weekly indicators showing mild bullishness and monthly indicators remaining bearish.

As of 12 May 2025, the technical trend for Smruthi Organic has changed from bearish to mildly bearish. The weekly MACD and KST are both mildly bullish, indicating some positive momentum, while the monthly MACD and KST remain bearish. The Bollinger Bands also show a mildly bullish stance on the weekly timeframe but are bearish on the monthly. Daily moving averages indicate a mildly bearish trend. Overall, the current stance is mildly bearish, driven primarily by the conflicting signals between the weekly and monthly indicators.

View full answer

What does Smruthi Organic do?

17-Jul-2025

Smruthi Organics Ltd is a Micro Cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of 381 Cr and a net profit of 22 Cr for the quarter ending March 2025. The company, incorporated in 1989, has a market cap of INR 143 Cr and key metrics including a P/E of 40.00 and a dividend yield of 2.41%.

Overview: <BR>Smruthi Organics Ltd operates in the Pharmaceuticals & Biotechnology industry and is classified as a Micro Cap company.<BR><BR>History: <BR>Smruthi Organics Limited was incorporated in July 1989 as a Private Limited Company and was subsequently converted into a Public Limited Company in February 1995. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 381 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 22 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 143 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 40.00 <BR>Industry P/E: 37 <BR>Dividend Yield: 2.41% <BR>Debt-Equity: 0.23 <BR>Return on Equity: 4.98% <BR>Price to Book: 1.99 <BR><BR>Contact Details: <BR>Address: 165-A Balaji Bhavan 1st Floor, Railway Lines Solapur Maharashtra : 413001 <BR>Tel: 91-217-2310267/2310268 <BR>Email: changale@smruthiorganics.com <BR>Website: http://www.smruthiorganics.com

View full answer

Who are the top shareholders of the Smruthi Organic?

17-Jul-2025

The top shareholders of Smruthi Organic are mainly promoters, with Eaga Purushotham Malaiah holding 41.23%. The highest public shareholder is Smitha Gupta at 1.21%, while individual investors collectively own 28.81% of the shares.

The top shareholders of Smruthi Organic are primarily the promoters, with Eaga Purushotham Malaiah holding the largest stake at 41.23%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) holding shares. The highest public shareholder is Smitha Gupta, who owns 1.21%. Additionally, individual investors collectively hold 28.81% of the shares.

View full answer

How big is Smruthi Organic?

24-Jul-2025

As of 24th July, Smruthi Organics Ltd has a market capitalization of 147.00 Cr, with Net Sales of 126.00 Cr and a Net Profit of 3.57 Cr reported in the latest four quarters. The company has Shareholder's Funds of 71.63 Cr and Total Assets of 111.74 Cr for the annual period ending March 2025.

As of 24th July, Smruthi Organics Ltd has a market capitalization of 147.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Smruthi Organics reported Net Sales of 126.00 Cr and a Net Profit of 3.57 Cr.<BR><BR>For the latest annual period ending March 2025, the company has Shareholder's Funds amounting to 71.63 Cr and Total Assets of 111.74 Cr.

View full answer

How has been the historical performance of Smruthi Organic?

17-Nov-2025

Smruthi Organic's historical performance shows declining net sales and total operating income from INR 141.04 crore in March 2023 to INR 126.01 crore in March 2025, despite a decrease in raw material costs and an increase in operating profit. Overall, the company has faced mixed financial results with fluctuating profits and cash flow.

Answer:<BR>The historical performance of Smruthi Organic shows a fluctuating trend in key financial metrics over the past several years.<BR><BR>Breakdown:<BR>Smruthi Organic's net sales have seen a decline from INR 141.04 crore in March 2023 to INR 126.01 crore in March 2025, with a peak in March 2023. The total operating income followed a similar trend, dropping from INR 141.04 crore in March 2023 to INR 126.01 crore in March 2025. The raw material costs decreased significantly from INR 95.69 crore in March 2023 to INR 67.86 crore in March 2025, contributing to a reduction in total expenditure, which fell from INR 131.26 crore in March 2023 to INR 113.83 crore in March 2025. Operating profit (PBDIT) has also fluctuated, reaching INR 12.27 crore in March 2025, up from INR 9.89 crore in March 2023. However, profit before tax showed a slight increase from INR 4.49 crore in March 2023 to INR 4.90 crore in March 2025, while profit after tax decreased from INR 4.13 crore in March 2023 to INR 3.56 crore in March 2025. The company's total assets increased from INR 105.64 crore in March 2023 to INR 111.74 crore in March 2025, while total liabilities rose from INR 105.64 crore to INR 111.74 crore in the same period. Cash flow from operating activities improved to INR 9.00 crore in March 2025 from INR 12.00 crore in March 2023, indicating a mixed performance in cash generation. Overall, Smruthi Organic's financial performance reflects a challenging environment with varying trends in sales, profits, and expenses.

View full answer

When is the next results date for Smruthi Organics Ltd?

06-Feb-2026

The next results date for Smruthi Organics Ltd is 13 February 2026.

The next results date for Smruthi Organics Ltd is scheduled for 13 February 2026.

View full answer

Are Smruthi Organics Ltd latest results good or bad?

14-Feb-2026

Smruthi Organics Ltd's latest Q3 FY26 results are concerning, with a 32.04% decline in net profit to ₹1.40 crores and a 29.46% drop in revenue to ₹22.29 crores, indicating significant volatility and ongoing demand challenges. Investors should approach with caution due to these trends.

Smruthi Organics Ltd's latest results for Q3 FY26 indicate a challenging performance. The company reported a net profit of ₹1.40 crores, which is a significant decline of 32.04% compared to the previous quarter. Revenue also fell sharply by 29.46%, dropping to ₹22.29 crores. This decline follows a previous quarter where revenue had surged by 66.40%, highlighting a concerning volatility in sales.<BR><BR>While the operating margin improved to 17.95%, up from 15.85% in the prior quarter, this was overshadowed by the substantial drop in both revenue and net profit. The year-on-year comparison shows a revenue contraction of 28.67%, suggesting ongoing demand challenges.<BR><BR>Overall, the results reflect significant revenue volatility and declining profitability, raising concerns about the company's stability and growth prospects. Investors may want to approach with caution given these trends.

View full answer

Should I buy, sell or hold Smruthi Organics Ltd?

06-Mar-2026

Why is Smruthi Organics Ltd falling/rising?

26-Mar-2026

As of 26-Mar, Smruthi Organics Ltd's stock price is slightly rising at 108.55, following a trend reversal after four days of decline, but it remains below key moving averages and has underperformed its sector. Despite increased investor interest and positive short-term financial metrics, long-term challenges persist, including declining sales and profits.

As of 26-Mar, Smruthi Organics Ltd's stock price is rising slightly, with a current price of 108.55, reflecting a change of 0.45 (0.42%) upward. This increase comes after a trend reversal, as the stock has gained after four consecutive days of decline. However, it is important to note that despite this recent uptick, the stock has underperformed its sector by 1.47% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally weak performance.<BR><BR>Investor participation has shown some positive signs, with a notable increase in delivery volume by 61.89% against the 5-day average, suggesting that more investors are willing to hold the stock. Additionally, the company has reported positive financial metrics, such as a higher profit after tax of Rs 3.85 crore and a strong return on capital employed (ROCE) of 10.57%. The stock is also trading at a discount compared to its peers, which may attract some investors looking for value.<BR><BR>However, the long-term outlook remains concerning, as the company has experienced a decline in net sales and operating profit over the past five years, with annual rates of -2.78% and -19.96%, respectively. Furthermore, the stock has consistently underperformed against benchmarks over the last three years, generating a return of -6.82% in the past year. These factors contribute to a mixed sentiment around the stock, with short-term gains overshadowed by long-term challenges.

View full answer

Why is Smruthi Organics Ltd falling/rising?

27-Mar-2026

As of 27-Mar, Smruthi Organics Ltd's stock price is Rs 105.00, down 3.54%, and has significantly underperformed against benchmarks, with a year-to-date decline of 10.18%. The stock is near its 52-week low and shows a bearish trend, compounded by decreased investor participation and poor long-term growth metrics.

As of 27-Mar, Smruthi Organics Ltd's stock price is falling, currently at Rs 105.00, which reflects a decrease of Rs 3.85 or 3.54%. The stock has underperformed significantly against the benchmark indices, with a 1-week decline of 6.46% compared to a 1.27% drop in the Sensex. Over the past month, the stock has also decreased by 6.29%, while the Sensex fell by 9.48%. Year-to-date, the stock is down 10.18%, which is better than the Sensex's decline of 13.66%.<BR><BR>Today's performance indicates that the stock is close to its 52-week low, being only 1.9% away from Rs 103. The stock reached an intraday low of Rs 104.25, marking a decline of 4.23%. Additionally, it is trading below all its moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which suggests a bearish trend.<BR><BR>Investor participation has also decreased, with delivery volume dropping by 18.65% compared to the 5-day average. This decline in trading activity may signal a lack of confidence among investors. Furthermore, the company has shown poor long-term growth, with net sales declining at an annual rate of 2.78% and operating profit decreasing by 19.96% over the last five years. This consistent underperformance against benchmarks over the last three years, coupled with the recent negative price movements, contributes to the stock's current downward trajectory.

View full answer

Why is Smruthi Organics Ltd falling/rising?

28-Mar-2026

As of 28-Mar, Smruthi Organics Ltd's stock price is Rs 105.00, reflecting a 3.54% decline. The stock has underperformed significantly over various periods, with a year-to-date drop of 10.18% and concerns about long-term growth prospects.

As of 28-Mar, Smruthi Organics Ltd's stock price is falling, currently at Rs 105.00, which reflects a decrease of Rs 3.85 or 3.54%. This decline is evident in the stock's performance over various periods, showing a 6.46% drop over the past week and a 6.29% decrease over the past month. Year-to-date, the stock has fallen by 10.18%, while it has underperformed the benchmark Sensex, which has declined by 13.66% in the same timeframe.<BR><BR>Today's trading performance indicates that the stock is close to its 52-week low, just 1.9% away from Rs 103. The stock also touched an intraday low of Rs 104.25, marking a 4.23% decrease during the day. Additionally, it has underperformed its sector by 2.67% today. The trading volume has shown a significant decline, with delivery volume on March 25 falling by 18.65% compared to the 5-day average, indicating reduced investor participation.<BR><BR>Moreover, Smruthi Organics Ltd is trading below its moving averages across multiple timeframes, including the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which typically signals a bearish trend. The company's long-term growth prospects are also concerning, as net sales have decreased at an annual rate of 2.78%, and operating profit has declined by 19.96% over the last five years. This consistent underperformance against the benchmark over the last three years further contributes to the stock's negative sentiment among investors.

View full answer

Why is Smruthi Organics Ltd falling/rising?

29-Mar-2026

As of 29-Mar, Smruthi Organics Ltd's stock price is at Rs 105.00, down 3.54%, and has significantly underperformed recently, with a year-to-date decline of 10.18%. The stock is near its 52-week low and shows a bearish trend, reflecting reduced investor confidence.

As of 29-Mar, Smruthi Organics Ltd's stock price is falling, currently at Rs 105.00, which reflects a decrease of Rs 3.85 or 3.54%. The stock has underperformed significantly in the short term, with a 1-week decline of 6.46% compared to a 1.27% drop in the Sensex. Over the past month, the stock has decreased by 6.29%, while the benchmark index has fallen by 9.48%. Year-to-date, Smruthi Organics Ltd has seen a decline of 10.18%, although this is slightly better than the Sensex's 13.66% drop.<BR><BR>The stock is currently trading close to its 52-week low, just 1.9% away from Rs 103. Today's performance has also been weak, with the stock underperforming its sector by 2.67%. It reached an intraday low of Rs 104.25, marking a 4.23% decrease during the trading session. Additionally, the stock is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend.<BR><BR>Investor participation has also declined, as evidenced by a drop in delivery volume of 18.65% against the 5-day average. This reduced activity suggests a lack of confidence among investors, contributing to the stock's downward movement. Overall, these factors indicate that Smruthi Organics Ltd is experiencing a decline in its stock price.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor long term growth as Net Sales has grown by an annual rate of -2.78% and Operating profit at -19.96% over the last 5 years

 
2

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 120 Cr (Micro Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

32

stock-summary
Dividend Yield

1.43%

stock-summary
Debt Equity

0.11

stock-summary
Return on Equity

7.03%

stock-summary
Price to Book

1.70

Revenue and Profits:
Net Sales:
22 Cr
(Quarterly Results - Dec 2025)
Net Profit:
1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.43%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-15.64%
0%
-15.64%
6 Months
-22.66%
0%
-22.66%
1 Year
-11.33%
1.32%
-10.01%
2 Years
-32.24%
2.00%
-30.24%
3 Years
-22.93%
3.61%
-19.32%
4 Years
-56.53%
3.39%
-53.14%
5 Years
-57.69%
4.47%
-53.22%

Latest dividend: 1.5 per share ex-dividend date: Jun-13-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Intimation Under Regulation 30 Of SEBI (LODR) Regulations - Receipt Of CEP Certificate From EDQM

09-Mar-2026 | Source : BSE

We are pleased to inform that the Company has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & Helathcare (EDQM) Europe for its product Amlodipine Besilate.

Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Receipt Of Attestation Of Inspection From EDQM

04-Mar-2026 | Source : BSE

Receipt of Attestation of Inspection from EDQM

Announcement under Regulation 30 (LODR)-Newspaper Publication

16-Feb-2026 | Source : BSE

Newspaper Advertisement- Financial Results

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Smruthi Organics Ltd has declared 15% dividend, ex-date: 13 Jun 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Smruthi Organics Ltd has announced 2:1 bonus issue, ex-date: 16 Mar 21

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-2.78%
EBIT Growth (5y)
-19.96%
EBIT to Interest (avg)
6.60
Debt to EBITDA (avg)
0.84
Net Debt to Equity (avg)
0.11
Sales to Capital Employed (avg)
1.72
Tax Ratio
18.73%
Dividend Payout Ratio
48.19%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
15.98%
ROE (avg)
9.85%

Valuation key factors

Factor
Value
P/E Ratio
23
Industry P/E
32
Price to Book Value
1.60
EV to EBIT
15.53
EV to EBITDA
8.73
EV to Capital Employed
1.54
EV to Sales
1.09
PEG Ratio
0.31
Dividend Yield
1.52%
ROCE (Latest)
10.49%
ROE (Latest)
7.03%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Eaga Purushotham Malaiah (41.23%)

Highest Public shareholder

0 (1.21%)

Individual Investors Holdings

28.83%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -29.46% vs 66.40% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -32.04% vs 287.27% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "22.29",
          "val2": "31.60",
          "chgp": "-29.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.00",
          "val2": "5.01",
          "chgp": "-20.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.25",
          "val2": "0.66",
          "chgp": "-62.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.45",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.40",
          "val2": "2.06",
          "chgp": "-32.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.95%",
          "val2": "15.85%",
          "chgp": "2.10%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -10.71% vs -12.16% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 740.00% vs -103.44% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "50.59",
          "val2": "56.66",
          "chgp": "-10.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.24",
          "val2": "3.34",
          "chgp": "56.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.12",
          "val2": "0.85",
          "chgp": "31.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.96",
          "val2": "-0.15",
          "chgp": "740.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.36%",
          "val2": "5.89%",
          "chgp": "4.47%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -17.10% vs -0.08% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 77.44% vs -35.75% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "72.88",
          "val2": "87.91",
          "chgp": "-17.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "9.24",
          "val2": "7.50",
          "chgp": "23.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.37",
          "val2": "1.36",
          "chgp": "0.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.45",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.36",
          "val2": "1.33",
          "chgp": "77.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.68%",
          "val2": "8.53%",
          "chgp": "4.15%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -1.28% vs -9.50% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -0.84% vs -13.08% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "126.01",
          "val2": "127.64",
          "chgp": "-1.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12.18",
          "val2": "11.95",
          "chgp": "1.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.87",
          "val2": "1.41",
          "chgp": "32.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "3.56",
          "val2": "3.59",
          "chgp": "-0.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.67%",
          "val2": "9.36%",
          "chgp": "0.31%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
22.29
31.60
-29.46%
Operating Profit (PBDIT) excl Other Income
4.00
5.01
-20.16%
Interest
0.25
0.66
-62.12%
Exceptional Items
-0.45
0.00
Standalone Net Profit
1.40
2.06
-32.04%
Operating Profit Margin (Excl OI)
17.95%
15.85%
2.10%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is -29.46% vs 66.40% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -32.04% vs 287.27% in Sep 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
50.59
56.66
-10.71%
Operating Profit (PBDIT) excl Other Income
5.24
3.34
56.89%
Interest
1.12
0.85
31.76%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.96
-0.15
740.00%
Operating Profit Margin (Excl OI)
10.36%
5.89%
4.47%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -10.71% vs -12.16% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is 740.00% vs -103.44% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
72.88
87.91
-17.10%
Operating Profit (PBDIT) excl Other Income
9.24
7.50
23.20%
Interest
1.37
1.36
0.74%
Exceptional Items
-0.45
0.00
Standalone Net Profit
2.36
1.33
77.44%
Operating Profit Margin (Excl OI)
12.68%
8.53%
4.15%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is -17.10% vs -0.08% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 77.44% vs -35.75% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
126.01
127.64
-1.28%
Operating Profit (PBDIT) excl Other Income
12.18
11.95
1.92%
Interest
1.87
1.41
32.62%
Exceptional Items
0.00
0.00
Standalone Net Profit
3.56
3.59
-0.84%
Operating Profit Margin (Excl OI)
9.67%
9.36%
0.31%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is -1.28% vs -9.50% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is -0.84% vs -13.08% in Mar 2024

stock-summaryCompany CV
About Smruthi Organics Ltd stock-summary
stock-summary
Smruthi Organics Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Smruthi Organics Limited was incorporated in July, 1989 as a Private Limited Company and was subsequently converted into a Public Limited Company in February, 1995. The Company was promoted by E Purushotham and Shankarrao R Myakal.
Company Coordinates stock-summary
Company Details
165-A Balaji Bhavan 1st Floor, Railway Lines Solapur Maharashtra : 413001
stock-summary
Tel: 91-217-2310267/2310268
stock-summary
changale@smruthiorganics.com
Registrar Details
Adroit Corporate Services Pvt Ltd, 17-20 Jaferbhoy Industrial Estate , 1st Floor, Makwana Road, Marol Naka, Mumbai